Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer

Yun Gyoung Kim(Korea Institute of Radiological and Medical Sciences), Woo Chul Noh(Korea Institute of Radiological and Medical Sciences)
Oncotarget
December 20, 2017
Cited by 15


Related Papers